@misc{indiciae2ecfa8060020,
  title = {Receptor binding domain (RBD) antibodies contribute more to SARS-CoV-2 neutralization when target cells express high levels of ACE2},
  author = {Farrell, A. G. and Dadonaite, B. and Greaney, A. J. and Eguia, R. and Loes, A. N. and Francko, N. M. and Logue, J. and Carreno, J. M. and Abbad, A. and Chu, H. Y. and Matreyek, K. A. and Bloom, J. D.},
  year = {2022},
  doi = {10.1101/2022.08.29.505713},
  url = {https://www.biorxiv.org/content/10.1101/2022.08.29.505713v1},
  note = {Source identifier: 10.1101/2022.08.29.505713}
}